Us stocks with great technicals short term

``` The deep research logic is organized as follows: Okay, let's tackle this question. The user is asking for US stocks with great short-term technicals. They mentioned they're interested in AI stocks like IBRX and penny stocks for speculative gains. So, I need to focus on stocks that meet their criteria. First, I'll check the references provided. The user's query is about US stocks with strong short-term technicals. Looking at the references, there's a query (Number 2) that lists top 10 stocks based on percentage change, RSI >70, and other technical conditions. The results include Liminatus Pharma (LIMN), ModivCare (MODV), Newegg (NEGG), Babcock & Wilcox (BW), Brag House (TBH), etc. These stocks have high RSI, positive volume balance, and moving averages in an uptrend. The user is into AI and penny stocks, so I should highlight any stocks in those categories. From the list, Liminatus Pharma is a biotech company, which might not be AI, but ModivCare is a healthcare tech company. Newegg is an e-commerce tech company. Brag House is a tech-enabled platform. None are direct AI plays, but ModivCare and Newegg have tech elements. The user might be interested in these for their tech angle. The user also likes speculative penny stocks. Looking at the list, BW (Babcock & Wilcox) has a low price, as does TBH (Brag House). These could fit the penny stock criteria. The user's profile mentions a focus on short-term gains and technical analysis, so the high RSI and positive volume balance are key points. I need to structure the answer with a conclusion first, then detailed analysis. Use tables for clarity. Also, include visualizations for the query results. Make sure to cite the references properly. The user's interest in IBRX and speculative plays means I should mention if any of these stocks have similar setups, even if they're not direct competitors. Check the background for any news. Liminatus Pharma has recent news about regaining Nasdaq compliance, which could be a catalyst. ModivCare has a technical analysis with a buy rating. Newegg had a surge without news, possibly a short squeeze. Brag House is involved in naked short selling investigations, which could lead to volatility. The user's strategy is short-term, so the analysis should focus on entry points, stop-loss levels, and potential upside. Highlight the RSI levels, moving averages, and volume ratios. Also, mention the risks like overbought conditions and market volatility. Make sure to format the answer with markdown tables, bold key points, and include emojis for engagement. The visualization should be placed right after the relevant section. Since the user is into technicals, the analysis should be detailed but clear. Finally, ensure the answer is personalized, acknowledging their interest in AI and speculative stocks, and maybe suggest how these stocks align with their strategy. Keep the language encouraging and informative. ``` ### 🎯 **Top US Stocks with Strong Short-Term Technicals** Here’s a curated list of US stocks exhibiting **high RSI (>70)**, **positive volume balance**, and **bullish moving average convergence**, sorted by **quantitative recommendation score**. These stocks are ideal for **short-term traders** seeking high volatility and potential upside: --- ### 📊 **Top 10 Stocks (as of 2025-06-05)** | Rank | Stock Code | Stock Name | Last Price | % Change | RSI | Volume Ratio | MA5 vs MA10 vs MA20 | |------|------------|---------------------|------------|----------|-----|--------------|---------------------| | 1 | **LIMN** | Liminatus Pharma | $24.6 | **+93.55%** | **96.31** | **14.63** | 10.69 > 7.93 > 7.25 | | 2 | **MODV** | ModivCare | $4.16 | **+80.09%** | **89.56** | **1.93** | 2.34 > 1.67 > 1.36 | | 3 | **NEGG** | Newegg Commerce | $10.53 | **+67.68%** | **86.52** | **34.14** | 6.64 > 6.24 > 6.01 | | 4 | **BW** | Babcock & Wilcox | $1.35 | **+66.89%** | **86.72** | **39.3** | 0.9 > 0.81 > 0.77 | | 5 | **TBH** | Brag House Holdings | $0.9 | **+51.26%** | **87.87** | **889.52** | 0.64 > 0.61 > 0.6 | | 6 | **EYEN** | Eyenovia | $3.14 | **+50.96%** | **86.15** | **3.43** | 2.13 > 1.95 > 1.58 | | 7 | **PL** | Planet Labs | $5.96 | **+49.37%** | **93.92** | **13.93** | 4.28 > 4.07 > 3.92 | | 8 | **ZENA** | ZenaTech | $4.45 | **+39.94%** | **95.64** | **157.01** | 3.26 > 2.95 > 2.6 | | 9 | **GSIW** | Garden Stage | $1.02 | **+35.73%** | **83.36** | **12.07** | 0.8 > 0.77 > 0.7 | | 10 | **IMAB** | I-Mab | $2.29 | **+27.93%** | **90.98** | **2.43** | 1.71 > 1.41 > 1.16 | Closing Price > 5-Day Moving Average; 5-Day Moving Average > 10-Day Moving Average; 10-Day Moving Average > 20-Day Moving Average; RSI > 70; Volume Balance > 0; Top 10 Sorted by Percentage Change |code|stock code|stock name|Last Price|Last Change|Closing Price[20250605]|ma5[20250605]|ma10[20250605]|ma20[20250605]|RSI[20250605]|Volume Ratio[20250605]|Percentage Change[20250605]|market_code| |---|---|---|---|---|---|---|---|---|---|---|---|---| |LIMN|LIMN.O|Liminatus Pharma|24.6|93.548387|24.6|10.686|7.934|7.2482|96.313|14.6306|93.548387|185| |MODV|MODV.O|ModivCare|4.16|80.08658|4.16|2.342|1.6651|1.3566|89.5639|1.9327|80.08658|185| |NEGG|NEGG.O|Newegg Commerce|10.53|67.675159|10.53|6.641|6.243|6.0098|86.5246|34.1433|67.675159|186| |BW|BW.N|Babcock & Wilcox|1.35|66.89331200000001|1.35|0.8984|0.8092|0.7736|86.719|39.3042|66.89331200000001|169| |TBH|TBH.O|Brag House Holdings|0.9|51.260504|0.9|0.6446|0.6122|0.6048|87.8744|889.5217|51.260504|186| |EYEN|EYEN.O|Eyenovia|3.14|50.961538|3.14|2.134|1.95|1.5826|86.1491|3.425|50.961538|186| |PL|PL.N|Planet Labs|5.96|49.373433999999996|5.96|4.284|4.069|3.9245|93.9181|13.9335|49.373433999999996|169| |ZENA|ZENA.O|ZenaTech|4.45|39.937107|4.45|3.262|2.947|2.603|95.6367|157.014|39.937107|186| |GSIW|GSIW.O|Garden Stage|1.02|35.728543|1.02|0.8046|0.7662|0.7024|83.3566|12.0686|35.728543|186| |IMAB|IMAB.O|I-Mab|2.29|27.932961|2.29|1.708|1.405|1.1555|90.9816|2.4348|27.932961|185| --- ### 📊 **Key Observations** 1. **Liminatus Pharma (LIMN)**: - **Catalyst**: Regained Nasdaq compliance after delayed 10-Q filing . - **Technical Setup**: RSI **96.31** (extremely overbought), Volume Ratio **14.63** (high liquidity). - **Risk**: Potential short-term pullback due to overbought conditions. 2. **ModivCare (MODV)**: - **Catalyst**: Technology-enabled healthcare services with recent institutional buy signals . - **Technical Setup**: RSI **89.56**, Volume Ratio **1.93** (low liquidity). - **Risk**: High volatility due to small market cap ($33.16M) . 3. **Newegg Commerce (NEGG)**: - **Catalyst**: No news, but **73.5% surge** driven by retail speculation . - **Technical Setup**: RSI **86.52**, Volume Ratio **34.14** (massive trading activity). - **Risk**: Short squeeze potential due to **5.7% short interest** . 4. **Brag House Holdings (TBH)**: - **Catalyst**: Investigating naked short selling allegations . - **Technical Setup**: RSI **87.87**, Volume Ratio **889.52** (extreme liquidity). - **Risk**: Regulatory uncertainty and high market cap volatility ($6.6M) . 5. **I-Mab (IMAB)**: - **Catalyst**: Biotech pipeline with **CD38 antibody trials** . - **Technical Setup**: RSI **90.98**, Volume Ratio **2.43** (moderate liquidity). - **Risk**: Early-stage clinical trials with high execution risk. --- ### 📊 **Strategic Takeaways** - **Entry Strategy**: Focus on **LIMN** (Nasdaq compliance) and **NEGG** (short squeeze potential) for high-impact setups. - **Exit Strategy**: Set **stop-loss** at 5-day moving average (e.g., $10.69 for LIMN) and **target** at 20-day moving average (e.g., $7.25 for LIMN). - **Risk Management**: Monitor **RSI divergence** (e.g., LIMN’s RSI **96.31** vs. price action) and **volume spikes** (e.g., TBH’s Volume Ratio **889.52**). Let me know if you’d like to dive deeper into any specific stock! 🚀